Search Login Register

Primary Effusion Lymphoma Summary

Description: A rare neoplasm of large B-cells usually presenting as serious effusions without detectable tumor masses. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. It is associated with HUMAN HERPESVIRUS 8, most often occurring in the setting of immunodeficiency.

Also Known As: Lymphoma, Primary Effusion; Effusion Lymphoma, Primary; Effusion Lymphomas, Primary; Lymphomas, Primary Effusion; Primary Effusion Lymphomas

Networked: 496 relevant articles (12 outcomes, 12 trials/studies) for this Disease

Key Drugs and Agents for Primary Effusion Lymphoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Multi-centric Castleman's Disease : 1 outcome 3 studies in 227 results : IBA
  2. DNA (Deoxyribonucleic Acid) : 1 outcome 1 study in 17 results : IBA
  3. bortezomib (Velcade) : 1 outcome 1 study in 9 results : FDA 1
  4. cidofovir (Vistide) : 1 outcome 1 study in 6 results : FDA 1
  5. Ribonuclease P (RNase P) : 1 outcome 1 study in 1 result : IBA
  6. rituximab (Mabthera) : 1 outcome in 6 results : FDA 3
  7. Antibodies : 1 outcome in 5 results : IBA
  8. Ganciclovir (Cytovene) : 1 outcome in 2 results : FDA 7 Generic
  9. sobuzoxane : 1 outcome in 2 results : IBA
  10. lenalidomide (CC 5013) : 1 outcome in 1 result : FDA 2
Show All >>

Diseases Related to Primary Effusion Lymphoma

  1. Kaposi Sarcoma (Kaposi's Sarcoma)
  2. Neoplasms (Cancer)
  3. Acquired Immunodeficiency Syndrome (AIDS)
  4. Liver Cirrhosis (Hepatic Cirrhosis)
  5. Lymphoma (Lymphomas)
Show All >>

Key Therapies for Primary Effusion Lymphoma

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 2 outcomes in 17 results
  2. Heterologous Transplantation (Xenotransplantation) : 1 outcome in 4 results
  3. Radiotherapy : 1 outcome in 1 result
  4. Transplants (Transplant) : 8 results
  5. Transplantation (Transplant Recipients) : 8 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.